Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carel

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990
Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gammaJ C Carel, R D Schreiber, L Falqui, et al.
European Journal of Endocrinology|February 26, 1999
Long-term results of GH therapy in GH-deficient children treated before 1 year of ageF Huet, J C Carel, J L Nivelon, et al.
Diabetes|January 1, 1996
Long-term results of early cyclosporin therapy in juvenile IDDMG De Filippo, J C Carel, C Boitard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cellsJ C Carel, B Frazier, T J Ley, et al.
Diabetes & Metabolism|July 1, 1996
Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatmentJ C Carel, J L Chaussain, P Chatelain, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 16, 1998
[Catch-up growth in growth hormone deficit children treated with GH since the first year of life]F Huet, J C Carel, J L Nivelon, et al.
Diabetes & Metabolism|October 29, 1997
Insulin and the prevention of insulin-dependent diabetes mellitusR Coutant, J C Carel, J Timsit, et al.
Journal of Autoimmunity|December 1, 1995
Reactivity of islet cell antibodies (ICA) to recombinant glutamic acid decarboxylase (GAD)L Guazzarotti, C Thivolet, I Tardivel, et al.
The Journal of Biological Chemistry|July 25, 1990
Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infectionJ C Carel, B L Myones, B Frazier, et al.
European Journal of Pediatrics|February 27, 1999
Conversion reaction: management by the paediatricianA Zeharia, M Mukamel, C Carel, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990
Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gammaJ C Carel, R D Schreiber, L Falqui, et al.
European Journal of Endocrinology|February 26, 1999
Long-term results of GH therapy in GH-deficient children treated before 1 year of ageF Huet, J C Carel, J L Nivelon, et al.
Diabetes|January 1, 1996
Long-term results of early cyclosporin therapy in juvenile IDDMG De Filippo, J C Carel, C Boitard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cellsJ C Carel, B Frazier, T J Ley, et al.
Diabetes & Metabolism|July 1, 1996
Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatmentJ C Carel, J L Chaussain, P Chatelain, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 16, 1998
[Catch-up growth in growth hormone deficit children treated with GH since the first year of life]F Huet, J C Carel, J L Nivelon, et al.
Diabetes & Metabolism|October 29, 1997
Insulin and the prevention of insulin-dependent diabetes mellitusR Coutant, J C Carel, J Timsit, et al.
Journal of Autoimmunity|December 1, 1995
Reactivity of islet cell antibodies (ICA) to recombinant glutamic acid decarboxylase (GAD)L Guazzarotti, C Thivolet, I Tardivel, et al.
The Journal of Biological Chemistry|July 25, 1990
Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infectionJ C Carel, B L Myones, B Frazier, et al.
European Journal of Pediatrics|February 27, 1999
Conversion reaction: management by the paediatricianA Zeharia, M Mukamel, C Carel, et al.
Pageof 13